CureVac AG

CureVac AG

CureVac AG

Founded in 2000 as a spinoff from the University of Tbingen in Germany, CureVac is a technology leader in the development of drugs that are based on the molecule Messenger RNA (mRNA).
Founded
2000
Raised
$29.5M
Follow us
Featured on
Alexa global traffic share